We Support New Ideas

Our mission:
to fund new ideas at their inception

The Society’s independently judged, peer-reviewed research grants are highly valued by researchers and considered important and prestigious within the scientific community.

The Society has funded research projects by most of Canada’s top glaucoma researchers – doctors and scientists interested in finding new treatments and in preventing blindness from glaucoma. These highly respected researchers are recognized across Canada and internationally.

Their research includes:

  • seeking to protect good nerve cells in the eye and repair damaged ones
  • searching for genes related to glaucoma
  • improving blood flow to the eye, and
  • making glaucoma surgery easier for the patient.

80% of funds raised go directly to researchers

Sound governance, a volunteer board, and low administration costs ensure that more than 80% of funds raised by the Society go directly to Canadian researchers.

The Glaucoma Research Society of Canada is the only Canadian non-profit organization solely dedicated to funding glaucoma research. Since 1989, it has raised more than two million dollars in support of 150 research projects. The Society funds 10 to 15% of all independent glaucoma research in Canada.

Glaucoma Research Society of Canada grants $300,000 for 16 research projects in 2016

  • Identification of the genetic basis of pigmentary glaucoma in Mennonite families using whole exome sequencing (Renewal) – Dr. Michael A. Walter, Dr. Ordan J. Lehmann, University of Alberta Edmonton, AB
  • Relationship between gaze behavior and mobility deficits in individuals with glaucoma (Renewal) – Dr. Dan Marigold, Dr. Kim Zebehazy, Simon Fraser University, Burnaby, BC
  • Changes in lamina cribrosa depth as an early marker of glaucoma progression – Dr. Jayme R. Vianna, Dr. Balwantray C. Chauhan, Dalhousie University, Halifax NS
  • Mechanisms underlying excess matrix deposition in the trabecular meshwork in glaucoma (Renewal) – Dr. Sunil Parapuram, Lawson Health Research Institute, University of Western Ontario, London, ON
  • Markov model to evaluate istent with phacoemulsification for patients with cataract and glaucoma – Dr. Monali Malvankar, Dr. Cindy Hutnik, Lawson Health Research Institute/Ivey Eye Institute, London, ON
  • Randomized control trial of retrobulbar injection vs IV analgesia for transscleral diode laser – Dr. Delan Jinapriya, Dr. Isabella Irrcher, Dr. Dale Engen, Queen’s University, Kingston, ON
  • Efficacy of PGC-1a induction on retinal ganglion cells (Final Renewal) – Dr. Jeremy Sivak, Krembil Research Institute/Toronto Western Hospital, Toronto, ON
  • Biometric and refractive status of a Canadian narrow angle patient population and the degree of angle opening post peripheral iridotomy – Dr. Delan Jinapriya, Dr. Eddie Moss, Dr. Harman Singh, Dr. Isabella Irrcher, Queen’s University, Kingston, ON
  • Development of a preference-based disease-specific health-related quality of life instrument for glaucoma – Dr. Iqbal Ike Ahmed, Dr. Feng Xie, University of Toronto, Toronto, ON; Dr. Dominik Podbielski, Sergei Muratov, McMaster University, Hamilton, ON
  • Combination therapies for the treatment of glaucoma (Renewal) – Dr. Catherine Tsilfidis, Ottawa Hospital Research Institute, Ottawa, ON
  • Establishment of a genetic database in open angle glaucoma – Dr. Andrew C. Orr, Dr. Paul E. Rafuse, Dalhousie University, Halifax, NS
  • Portable perimeter (Renewal) – Dr. Moshe Eizenman, Dr. Jonathan Rose, University of Toronto, Toronto, ON
  • The effect of oral glucose tolerance tests on IOP, visual fields, anterior segment and choroidal changes in diabetic and glaucoma patients – Dr. Enitan Sogbesan, McMaster University, Hamilton, ON
  • Establishment of a zebrafish model for translational glaucoma research – Dr. Curtis R. French, Memorial University of Newfoundland, St. John’s, NL
  • Subtenons triamcinolone acetonide injections for treatment of persistent choroidal effusions post glaucoma surgery – Dr. Catherine Birt, Dr. Kenneth Eng, Dr. C. Kranemann, Dr. A. Bonniard, Sunnybrook Health Sciences Centre, Toronto, ON
  • Are protein deposits discovered in the eyes of dementia patients different from deposits in pseudoexfoliation glaucoma? – Dr. Neeru Gupta, Dr. Yeni Yücel, St. Michael’s Hospital, Toronto, ON
at work in the lab Dr. Alexander Ball’s 2009 Lab Group

Your donations have funded numerous scientists who have gained international respect and reputations in advancing research into glaucoma.

The next decade should see some important breakthroughs including methods to maintain and possibly even repair damaged optic nerves in glaucoma.

Your support is essential to continue this valuable and much needed research.

Research Grant Applications

Researchers into glaucoma from across Canada apply annually for funding. Independent peers review the applications under the guidance of the Scientific Advisory Committee of renowned ophthalmologists and scientists from across the country. The Committee makes funding recommendations to the Society's Board of Directors.

Applying for a Grant